RaQualia Pharma Inc
TSE:4579

Watchlist Manager
RaQualia Pharma Inc Logo
RaQualia Pharma Inc
TSE:4579
Watchlist
Price: 563 JPY 4.84%
Updated: May 31, 2024

RaQualia Pharma Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

RaQualia Pharma Inc
Pre-Tax Income Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
RaQualia Pharma Inc
TSE:4579
Pre-Tax Income
-¥294m
CAGR 3-Years
18%
CAGR 5-Years
23%
CAGR 10-Years
12%
Takeda Pharmaceutical Co Ltd
TSE:4502
Pre-Tax Income
¥52.8B
CAGR 3-Years
-48%
CAGR 5-Years
-16%
CAGR 10-Years
-10%
Daiichi Sankyo Co Ltd
TSE:4568
Pre-Tax Income
¥237.2B
CAGR 3-Years
47%
CAGR 5-Years
23%
CAGR 10-Years
8%
Otsuka Holdings Co Ltd
TSE:4578
Pre-Tax Income
¥163.5B
CAGR 3-Years
-6%
CAGR 5-Years
8%
CAGR 10-Years
-2%
Chugai Pharmaceutical Co Ltd
TSE:4519
Pre-Tax Income
¥444B
CAGR 3-Years
15%
CAGR 5-Years
28%
CAGR 10-Years
17%
Astellas Pharma Inc
TSE:4503
Pre-Tax Income
¥25B
CAGR 3-Years
-44%
CAGR 5-Years
-37%
CAGR 10-Years
-15%

See Also

What is RaQualia Pharma Inc's Pre-Tax Income?
Pre-Tax Income
-294m JPY

Based on the financial report for Dec 31, 2023, RaQualia Pharma Inc's Pre-Tax Income amounts to -294m JPY.

What is RaQualia Pharma Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
12%

The average annual Pre-Tax Income growth rates for RaQualia Pharma Inc have been 18% over the past three years , 23% over the past five years , and 12% over the past ten years .